Add like
Add dislike
Add to saved papers

Safety profile of outpatient vs inpatient ACDF: An analysis of 33,807 outpatient ACDFs.

INTRODUCTION: Anterior cervical discectomy and fusion (ACDF) is commonly performed to treat symptomatic cervical spondylolysis. Recently, many spine surgeons have begun performing ACDF in the outpatient setting. However, as this is a relatively new trend, many studies are either outdated or have small sample populations. The aim of this study was to evaluate outcomes following elective outpatient ACDF in comparison to those performed in the inpatient setting.

METHODS: Patients in Mariner Claims Database (2011-2017) undergoing outpatient elective ACDF were propensity score matched using age, gender and comorbidity burden. Chronic and peri-operative complications were assigned based on medical claims codes. All outcomes of interest were analyzed using multivariate logistic regression and compared to those undergoing inpatient ACDF. Significance was defined as p < 0.05 and adjusted with Bonferroni correction.

RESULTS: Outpatient surgery had significantly lower risk of dysphagia within 24 h in both single (OR 0.44, p < 0.001) and multilevel ACDF (OR 0.48, p < 0.001). Patients undergoing outpatient procedures also have lower risk of 90-day minor (Single OR 0.64, p < 0.001; Multilevel OR 0.52, p < 0.001) and major (Single OR 0.48, p < 0.001; Multilevel OR 0.57, p < 0.001) medical complications. Outpatient procedures were also associated with decreased hospital resource utilization with a noted lower risk of subsequent hospital readmission (Single OR 0.71, p < 0.001; Multilevel OR 0.60, p < 0.001) and ER visits (Single OR 0.84, p < 0.001; Multilevel OR 0.87, p < 0.001).

CONCLUSION: Outpatient single and multilevel ACDF may be performed safely in properly selected patients. Since there are relatively low rates of readmission and significant complications within the days following outpatient ACDF, many surgeons should consider transitioning carefully selected patients to an outpatient setting.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app